Tango Therapeutics, Inc.
TNGX
Kedudukan dalam Saham
#4538
Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and... Tango Therapeutics, Inc. is a biotechnology firm dedicated to the research and development of innovative cancer treatments. Their primary therapeutic candidate, TNG908, is a synthetic lethal small molecule designed to inhibit protein arginine methyltransferase 5 (PRMT5). This compound is currently being advanced as a potential therapy for cancers characterized by methylthioadenosine phosphorylase (MTAP) deletions. Additionally, their pipeline includes an Ubiquitin-specific protease 1 (USP1) inhibitor targeting BRCA1 or BRCA2-mutant cancers, and a program known as 'Target 3' which addresses STK11-mutant cancers. Tango Therapeutics maintains a strategic alliance with Gilead Sciences, Inc., focused on the identification, advancement, and commercialization of a diverse array of cancer therapies. Established in 2017, the company's operations are headquartered in Cambridge, Massachusetts.
Harga Saham
$27.18
Disegerakkan terakhir: 2026-07-31
Modal Pasaran
$3.38B
Perubahan (1 hari)
-1.41%
Perubahan (1 tahun)
201.00%
Negara
US
Perdagangan Tango Therapeutics, Inc. (TNGX)
Kategori
Healthcare
EPS untuk Tango Therapeutics, Inc. (TNGX)
EPS setakat June 2026 TTM: $-0.85
Menurut laporan kewangan terkini dan harga saham Tango Therapeutics, Inc., EPS semasa syarikat (TTM) adalah $-0.85. Pada akhir tahun 2023, syarikat mempunyai EPS sebanyak $-1.08 penurunan berbanding EPS tahun 2022 iaitu $-1.23.
Sejarah EPS untuk Tango Therapeutics, Inc. dari 2019 hingga 2026
EPS pada akhir setiap tahun
| Tahun | EPS | Ubah |
|---|---|---|
| 2026 (TTM) | $-0.85 | -28.57% |
| 2024 | $-1.19 | 10.19% |
| 2023 | $-1.08 | -12.20% |
| 2022 | $-1.23 | 30.85% |
| 2021 | $-0.94 | -41.98% |
| 2020 | $-1.62 | 3.18% |
| 2019 | $-1.57 | 0.00% |
EPS untuk syarikat atau pesaing yang serupa
| Syarikat | EPS | Perbezaan EPS | Negara |
|---|---|---|---|
| $17.32 | -2,137.65% |
US
|
|
| $-7.98 | 838.82% |
US
|
|
| $-5.29 | 522.35% |
AU
|
|
| - | - |
CH
|
|
| $27.74 | -3,363.53% |
NL
|
